In this article, we will take a detailed look at 10 Stocks Insiders Spent The Most Money On Recently. We previously covered 10 Stocks Insiders Are Buying This Year.
As the broader market continues to rise this year, we thought it would be interesting to highlight some stocks that have seen significant insider buying recently. Insiders—such as executives and directors—often have valuable insights into a company’s strategy, plans, and future initiatives. For instance, when a CEO or CFO invests their own money to purchase company shares, it can be seen as a strong vote of confidence in the company’s prospects. When an insider makes a substantial financial commitment, it often signals an even higher level of confidence in the company’s future performance.
Why should we be interested in insider trading activity? While both insider selling and buying can be driven by various motives, it is important to consider these moves within the broader context of the company’s fundamentals, industry trends, and overall market conditions. That’s why due diligence before any investment is of the utmost importance. However, insider trading activity in combination with other relevant determinants can offer valuable insights into a company’s capabilities, helping investors make more informed investment decisions.
What are some of the stocks that have seen the most insider investment recently? To find out, we used Insider Monkey’s insider trading stock screener, focusing only on stocks where each individual insider purchase was valued at $2 million or more. This means the total value of insider purchases over the same period (last 60 days) could be higher, but only larger purchases were considered in the search.
Our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds, focusing on insider trading and stock picks from hedge fund investor newsletters and conferences. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 275% since May 2014, beating its benchmark by 150 percentage points (see more details here).
With each stock, we note the value of acquired shares, which refers to the value of shares acquired through individual insider purchases worth at least $2 million each. Let’s take a look at 10 Stocks Insiders Spent The Most Money On Recently.
An overhead view of the financial district with busy traders on the trading floor.
10. Verde Clean Fuels, Inc. (NASDAQ:VGAS)
Value Of Shares Acquired: $50,000,000.00
Market Cap: $173.743 million
Verde Clean Fuels is a renewable gasoline technology company developing projects in North America. The company is focused on the deployment of its innovative and proprietary liquid fuels processing technology via the development of commercial production plants. Verde’s syngas-to-gasoline plus process converts syngas, derived from diverse feedstocks into fully finished liquid fuels that require no additional refining.
On January 29, one insider – Cottonmouth Ventures, LLC, a wholly-owned subsidiary of Diamondback Energy, Inc. (NASDAQ:FANG), acquired a total of $50 million worth of Verde Clean Fuels shares at a price of $4 per share. With this purchase of 12.5 million shares, Cottonmouth Ventures increased its holdings to 14.5 million shares.
The stock is currently trading at $3.92 per share, having declined 3.69% year-to-date. Over the past 12 months, Verde Clean Fuels shares dropped 25.76%.
For the three months ended September 30, 2024, the company disclosed a net loss of $2.5 million, which compares to a net loss of $2.6 million in the same period of 2023. The company’s net loss for the quarter was primarily attributable to ongoing and general and administrative expenses.
9. Smithfield Foods, Inc. (NASDAQ:SFD)
Value Of Shares Acquired: $64,000,000.00
Market Cap: $8.43 billion
The ninth stock on this list of top insider investments in recent weeks is a global food company and one of the world’s largest pork processors and hog producers – Smithfield Foods, Inc. The company went public this January.
Smithfield’s diversified portfolio includes well-known brands like Smithfield, Eckrich, Nathan’s Famous, Farmland, Farmer John, and Armour. The company was founded back in 1936, as Smithfield Packing Company. It is also one of the 15 Biggest Agriculture Stocks in 2025.
In January, one insider who is also a director at the company, Long Wan, acquired around $64 million worth of Smithfield shares at a price of $20 per share. Currently, the stock is trading at $21.45 per share, having gone up 8.58% since its IPO.
Since this is a new stock on the market, there’s not much analyst coverage on this stock yet. Usually, professional analysis requires the stock to be listed for a certain period of time.
8. Custom Truck One Source, Inc. (NYSE:CTOS)
Value Of Shares Acquired: $65,149,080.00
Market Cap: $1.12 billion
In the eighth spot among 10 stocks with significant insider spending lately is Custom Truck One Source – a single-source provider of specialized truck and heavy equipment solutions, such as sales, rentals, and financing. The company operates through three segments: Equipment Rental Solutions (ERS), Truck and Equipment Sales (TES), and Aftermarket Parts and Services (APS).
On January 30, two insiders acquired a total of around $65.15 million worth of shares, at a price of $4 per share. The stock is currently trading at $4.97 per share, having gained 3.33% year-to-date. Over the past 12 months, the stock dropped 27.52%.
For the third quarter of 2024, Custom Truck reported a total revenue of $447.2 million, up by 5.7% from the previous quarter. Gross profit amounted to $91.8 million, representing an increase of $2.6 million from the second quarter of 2024. Net loss was $17.4 million, a decrease of 28.9% compared to the second quarter of the year.
The company’s leadership expects that a rise in electricity demand due to AI and data centers presents a long-term growth opportunity for the company. Industry reports suggest a 24% to 29% increase in United States electricity demand by 2035.
Five analysts have an average “Buy” rating on Custom Truck stock, with a 12-month price target of $6.9, according to Stock Analysis.
Custom Truck is also considered one of the 12 Best Long-Term Penny Stocks to Buy According to Hedge Funds.
7. Mach Natural Resources LP (NYSE:MNR)
Value Of Shares Acquired: $79,999,995.00
Market Cap: $1.91 billion
Mach Natural Resources is an independent upstream oil and gas company with a focus on the acquisition, development, and production of oil, natural gas, and NGL reserves in the Anadarko Basin region of Western Oklahoma, Southern Kansas, and the panhandle of Texas. Its portfolio also includes midstream assets, plants, and water infrastructure.
On February 7th, Wallace William Mcmullen, a large shareholder and director at Mach Natural Resources, purchased around $80 million worth of the company’s shares, at a price of $15.50 per share. The stock is now trading at $16.40, having gone down 4.54% since the beginning of the year. The purchase was part of the company’s public offering of 12.90 million shares, out of which McMullen acquired about 5.16 million. After this purchase, Mcmullen raised his holdings to 74.29 million company shares.
For the third quarter of 2024, the company reported net income of $67.44 million, compared to net income of $83.49 million in the same period of 2023. Adjusted EBITDA was a gain of $133.97 million, which compares to adjusted EBITDA of $120.51 million in the same quarter of the prior year.
Mach Natural Resources Board of Directors recently declared a quarterly cash distribution for the fourth quarter of 2024 of $0.50 per unit.
As per data from StockAnalysis, three analysts have an average “Strong Buy” rating on Mach Natural Resources stock. Analysts also have a 12-month stock price forecast of $23.0, representing an increase of 40.24% from the previous price.
Over the last 12 months, the company’s shares declined 11.88%.
6. Metsera, Inc. (NASDAQ:MTSR)
Value Of Shares Acquired: $94,219,956.00
Market Cap: $3.31 billion
Sixth among 10 stocks insiders spent the most money on recently is Metsera, a clinical-stage biotechnology company. Metsera is engaged in the development of injectable and oral nutrient-stimulated hormone analog peptides to treat obesity and metabolic diseases. The New York City-headquartered company is working on a comprehensive portfolio of therapies with the potential to address various therapeutic targets and meet the needs of the weight loss treatment industry. It was founded in 2022 by Population Health Partners and ARCH Venture Partners.
On February 3, three insiders purchased a total of around $94.22 million worth of Metsera shares during the company’s initial public offering. Insiders acquired shares at a price of $18 per share. The company raised $257 million during its IPO, pricing shares above its targeted range. Currently, the stock is trading at $32.08 per share, having gained 21.06% since then.
In January, the company announced positive data from a 12-week Phase 2a clinical trial of its leading candidate – MET-097i, a potential once-monthly injectable treatment for obesity. The results revealed that MET-0971 helped participants lose weight (with some losing 20% of their body weight), and was well tolerated with mild side effects. The company plans further studies in 2025.
“MET-097i has the potential to be a foundational therapy for people with obesity and overweight, by virtue of its effectiveness, compelling tolerability profile and flexible options for dosing, including titration-free weekly dosing and monthly dosing,” commented John Buse, M.D., Verne S. Caviness Distinguished Professor and Director of the UNC Diabetes Center at University of North Carolina School of Medicine.
Currently, there is no analyst coverage available for this stock as it recently went public and coverage typically begins after a company has been listed for a certain period of time. We should expect analyst reports as the company matures in the market.
5. Sirius XM Holdings Inc. (NASDAQ:SIRI)
Value Of Shares Acquired: $96,443,369.86
Market Cap: $8.98 billion
Sirius XM is an audio entertainment company, which provides satellite radio and streaming services to more than 33 million subscribers in the U.S. Its offering includes a wide range of audio content, from music and sports to news and podcasts. The company was formed in 2008 through the merger of Sirius Satellite Radio and XM Satellite Radio to become SiriusXM Radio.
Over the last 60 days, one insider – Berkshire Hathaway Inc, purchased $96.66 million worth of Sirius XM Holdings shares at an average price of $20.76 per share. The stock is now trading at $26.52, having gone up 16.32% since the beginning of the year.
Sirius XM reported fourth-quarter and full-year 2024 revenue of $2.19 billion and $8.70 billion, respectively, representing declines of 4% and 3%, respectively, compared to the same periods in 2023. Out of the total revenue, subscribers revenue amounted to $1.65 billion, which compares to $1.73 billion in the comparable quarter of the prior year. The company reported net income of $287 million for the fourth quarter and a net loss of $2.08 billion for the full year 2024, compared to net income of $228 million and $988 million in the prior year, respectively.
Fifteen analysts have an average “Hold” rating on SIRI stock, with a 12-month target price of $27.04, representing an increase of 1.96% from the previous price, according to StockAnalysis.
Sirius XM is also considered one of the 12 Best Broadcasting Stocks to Buy Right Now.
4. Keurig Dr Pepper Inc. (NASDAQ:KDP)
Value Of Shares Acquired: $120,677,464.00
Market Cap: $44.02 billion
Keurig Dr Pepper, previously known under the names Green Mountain Coffee Roasters and Keurig Green Mountain, is a beverage and coffeemaker conglomerate. It was formed in 2018 via the merger of Keurig Green Mountain and Dr. Pepper Snapple Group. Its offering counts more than 125 hot and cold beverages. It owns the #1 single-serve coffee system in the US (Keurig) and has grown Dr. Pepper to become the second-largest soft drink brand in America, having overtaken Pepsi by the end of 2023.
The company recently unveiled its 2025 new flavor lineup in the U.S., which features brands like Dr. Pepper, 7UP, A&W and Snapple. The new offering comes after the viral popularity of Dr Pepper Creamy Coconut – the company’s most successful limited-time-offering carbonated soft drink (CSD) to date – and the introduction of Canada Dry Fruit Splash Cherry, which achieved the top spot among all new CSD flavor innovations for 2024.
On January 29, one insider, B.V. Holdings Maple, already a large shareholder of Keurig Dr Pepper acquired $120.68 million worth of shares, at a price of $33.34 per share. With this acquisition, B.V. Holdings Maple increased its holdings to 218,063,479 shares. The stock is currently trading at $32.45, having gained 1.03% since the beginning of the year.
The company’s net sales for the third quarter increased 2.3% to $3.9 billion. Operating cash flow for the third quarter was $628 million and free cash flow totaled $503 million. In February, the company’s Board of Directors declared a regular quarterly cash dividend of $0.23 per share.
Keurig Dr Pepper is also one of the 10 Best Dividend-Paying Beverage Stocks to Buy.
Data from TipRanks reveals that 15 Wall Street analysts have “Moderate Buy” as an average rating on Keurig Dr Pepper stock with a price target of $37.53.
3. Occidental Petroleum Corporation (NYSE:OXY)
Value Of Shares Acquired: $200,511,700.49
Market Cap: $45.83 billion
The third stock among the 10 with the highest insider investment recently is Occidental Petroleum. The company is focused on hydrocarbon exploration in the U.S. and the Middle East, and petrochemical manufacturing in the U.S., Canada, and Chile. Last year, the company significantly expanded its footprint in the Permian and Midland basins with the $12 billion acquisition of Crown Rock. This is also one of the 11 Best Natural Gas Stocks To Buy Now.
Over the last 60 days, one insider – Warren Buffett’s Berkshire Hathway Inc bought $200.51 million worth of Occidental Petroleum shares, at an average price of $46.23 per share. The stock is now trading at $48.84 per share, having declined 1.15% year-to-date. Over the past 12 months, the stock dropped 18%. With its latest purchase, Berkshire Hathway increased its holdings to 264,941,431 shares.
The company recently announced it has achieved its near-term debt repayment target of $4.5 billion in the fourth quarter of 2024. Furthermore, in the first quarter of 2025, Occidental Petroleum also signed two agreements to divest upstream assets to undisclosed buyers for a combined total of $1.2 billion.
For the fourth quarter of 2024, the company reported a net loss attributable to common stockholders of $297 million, or $0.32 per diluted share, and adjusted income attributable to common stockholders of $792 million, or $0.80 per diluted share, for the fourth quarter of 2024.
2. Immunovant, Inc. (NASDAQ:IMVT)
Value Of Shares Acquired: $336,900,200.00
Market Cap: $3.55 billion
The second on the list of top stocks insiders have been investing heavily in is a biotechnology company, Immunovant. The biotech is engaged in the development of new treatments for autoimmune disorders. The company is considered a trailblazer in anti-FcRn technology, and the company is working on innovative, targeted therapies to improve the lives of people with various autoimmune diseases.
During the third quarter of 2024, the company reported that five investigational new drug applications cleared across several therapeutic areas and FDA divisions for its leading drug, IMVT-1402. The company also said it is on track to commence the registration trial for IMVT-1402 across several indications by the end of March this year.
As of December 31, 2024, Immunovant’s cash and cash equivalents totaled $374.7 million. In the third quarter of 2024, the company had a net loss of $111.1 million ($0.76 per common share), compared to $51.4 million ($0.36 per common share) for the three months ended December 31, 2023.
On January 13th, one insider – Ltd. Sciences Roivant, acquired $336.9 million worth of Immunovant shares at a price of $20 per share. This way, Ltd. Sciences Roivant increased its holdings to 96,650,341. This purchase was part of the company’s $450 million private placement.
According to 8 Wall Street analysts, the average rating on Immunovant stock is “Strong Buy,” and a price target is set to $46.43 per share. This represents an increase of 120.57% from the previous price, according to data from TipRanks.
Immunovant shares are now trading at $20.89 per share, as the stock declined 15.66% since the beginning of the year. Over the last 12 months, the stock dropped 44.29%.
Immunovant is also one of 12 Stocks That Will Double in 2025.
1. TKO Group Holdings Inc (NYSE:TKO)
Value Of Shares Acquired: $805,295,312.70
Market Cap: $14.25 billion
The first among 10 stocks insiders spent the most money on recently is a global sports and entertainment company – TKO Group. It was created by Endeavor (NYSE:EDR) as part of a merger between World Wrestling Entertainment and Zuffa, LLC, the parent company of the Ultimate Fighting Championship.
TKO Group produces and licenses live events, TV programs, long- and short-form content, reality series, etc. Its content reaches more than 1 billion households across around 210 countries and territories. Each year, the company organizes more than 300 live events, attracting more than two million fans. The stock is also one of the 10 Top Insider Stock Buys And Sells In January.
Over the last 60 days, three insiders, including the company’s CEO, bought a total of around $805.3 million (considering only transactions worth more than $2 million) at an average price of $159.59 per share. The stock is currently trading at $166.05, having gained 16.85% since the beginning of the year. Over the past 12 months, TKO Group shares gained 93.62%.
In February, the company announced that UFC and Monster Energy have signed a multiyear renewal of their long-standing partnership, under which Monster will continue as the exclusive global Offical Energy Drink of UFC. TKO Group will release its earnings report for the fourth quarter of 2024 on February 26.
As many as 14 analysts have an average “Strong Buy” rating on the stock, with a 12-month price target of $146.46, reveals data from StockAnalysis.
Overall, TKO is first among the 10 Stocks Insiders Spent The Most Money On Recently. While we acknowledge the potential of TKO our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns, and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than TKO but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.
READ NEXT: 20 Best AI Stocks To Buy Now and Complete List of 59 AI Companies Under $2 Billion in Market Cap
Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.
Hedge Fund Resource Center